Pediatric Hematology and Oncology

Top Research Topics at Pediatric Hematology and Oncology?

Pediatric Hematology and Oncology focuses largely on the fields of Internal medicine, Surgery, Pediatrics, Chemotherapy and Immunology. Internal medicine research presented in it encompasses a variety of subjects, including Gastroenterology, Endocrinology, Oncology and Pathology. Lymphoma and Bone marrow are all topics related to Pathology research discussed.

Pediatric Hematology and Oncology encompasses presentations on Surgery, specifically Radiation therapy, Complication, Retrospective cohort study, Transplantation and Survival rate. Pediatrics research featured in it incorporates concerns from various other topics such as Cancer, Epidemiology, Disease and Incidence (epidemiology). Most of the works presented in Pediatric Hematology and Oncology deals with Chemotherapy but it intersects with the subject of Methotrexate.

The journal focuses on Immunology as well as the interrelated topic of Anemia. It features studies on Leukemia, including topics such as Acute leukemia.

• Internal medicine (34.93%)
• Surgery (23.14%)
• Pediatrics (18.72%)

What are the most cited papers published in the journal?

• Leukemia in Down Syndrome: A Review (208 citations)
• Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. (175 citations)
• Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. (163 citations)

Research areas of the most cited articles at Pediatric Hematology and Oncology:

The published articles aim to foster the development of research in Internal medicine, Surgery, Pediatrics, Chemotherapy and Immunology. The featured Internal medicine studies in the journal publications mainly concentrate on Gastroenterology but also cover areas of interest in Lymphoma and Pathology. While the primary focus in the most cited publications is Pediatrics, they also dissect topics surrounding Epidemiology and Cancer as a whole.

What topics the last edition of the journal is best known for?

• Internal medicine
• Cancer
• Disease

The previous edition focused in particular on these issues:

The discussions in the journal mainly cover the fields of Internal medicine, Pediatrics, Oncology, Chemotherapy and Cancer. The studies tackled, which mainly focus on Internal medicine, apply to Gastroenterology as well. The Gastroenterology works featured in the journal incorporate elements from Hematopoietic stem cell transplantation and Disease.

The research on Pediatrics presented in Pediatric Hematology and Oncology often intersects with areas of study such as

• Hemophagocytic lymphohistiocytosis together with Immunology,
• Single Center together with Lymphoma,
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is related to area like Coronavirus and Health care.. The journal explores issues in Oncology which can be linked to other research areas like Stem cell, Bone marrow, Cisplatin and Lymphoblastic Leukemia. Some problems in Chemotherapy that were presented in Pediatric Hematology and Oncology overlapped with concepts under Antibiotics, Methotrexate, Early discharge and Receiver operating characteristic.

The most cited articles from the last journal are:

• Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial. (4 citations)
• Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium. (3 citations)
• Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Pediatric Hematology and Oncology (based on the number of publications) are:

• Münevver Büyükpamukçu (49 papers) absent at the last edition,
• Canan Akyüz (33 papers) absent at the last edition,
• Bilgehan Yalçın (29 papers) published 1 paper at the last edition the same number as at the previous edition,
• Şinasi Özsoylu (28 papers) absent at the last edition,
• Aytemiz Gurgey (28 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Pediatric Hematology and Oncology (based on the number of publications) are:

• Boston Children's Hospital (372 papers) published 21 papers at the last edition, 9 more than at the previous edition,
• Hacettepe University (115 papers) published 1 paper at the last edition the same number as at the previous edition,
• Gazi University (51 papers) absent at the last edition,
• Ankara University (49 papers) absent at the last edition,
• Baylor College of Medicine (45 papers) published 8 papers at the last edition, 3 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.61% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 32.32% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.07% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 7.07% of all publications and 53.54% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Pediatric Hematology and Oncology

While contributing to the wealth of knowledge in pediatric hematology and oncology is fulfilling, many students and practitioners may also be curious about career opportunities in this field, particularly, how to secure a good role. While many different pathways exist in this profession, it's essential to gather as much information as possible about the various roles available and how to acquire the needed skills and qualification. One key role in this field is that of a registered nurse specializing in pediatric hematology and oncology. This role requires not only an understanding of general nursing principles but also specialized knowledge of disorders and diseases affecting children's blood cells and cancer. Nurses in this field work alongside doctors and medical researchers to provide vital care for young patients. In addition to being well-versed in the medical aspect, these nurses must also display an inherent aptitude for supporting children and their families during difficult times. If you desire to become a pediatric hematology and oncology nurse, you must first complete your Bachelor of Science in Nursing (BSN), pass the NCLEX-RN to receive your nursing license, and gain valuable clinical experience. Following this, you'll have to obtain certification in pediatric oncology nursing. It's important to note that these processes could differ slightly in various states. For instance, if you're based in Nebraska and interested in this career path, you can refer to our detailed guide [here](https://research.com/careers/how-to-become-a-nurse-in-nebraska "how to become a registered nurse in Nebraska online"). Nonetheless, career opportunities in pediatric hematology and oncology extend beyond the role of a nurse. Other viable roles include medical doctors, hematologists, oncologists, medical researchers, and lab technicians. Once again, each of these roles has unique qualifications, responsibilities, and expectations, making it crucial to thoroughly research and consider all these factors before making a career decision. In conclusion, whether one chooses to become a researcher, a doctor, a nurse, or fulfill any other role within this field, pediatric hematology and oncology can offer a rewarding career full of opportunities to make a significant impact on young lives. As we continue to advance in medicine and technology, the importance and demand for these professions will only continue to grow.